New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 19, 2012
06:14 EDTAEG, RY, ING, RIMM, CS, UBS, BBVA, RBS, JNJ, BCS, DB, LYG, STD, JPM, DOWOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: Europe's program to defuse its financial crisis by injecting cash into the banking system is running out of energy as interest rates rise and some banks have little cash left, the Wall Street Journal reports...Dow Chemical (DOW) and other chemical companies see new opportunities in the enormous domestic deposits of gas, the Wall Street Journal reports...REUTERS: U.S. coal exports to China could more than double to over 12M tons in 2012 due to depressed freight rates and a decline in U.S. demand, says Xcoal Energy & Resources CEO Thrasher, Reuters reports...Johnson & Johnson (JNJ) received EU clearance to purchase Swiss medical device maker Synthes for about $21B, Reuters reports...BLOOMBERG: Research In Motion (RIMM) is close to deciding on a financial adviser, and JPMorgan Chase (JPM) is said to be the leading candidate to help the company weigh strategy options, Bloomberg reports.
News For STD;RBS;ING;LYG;BBVA;RY;DB;UBS;AEG;BCS;CS;DOW;JNJ;RIMM;JPM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 25, 2015
14:20 EDTJPMFormer JPMorgan analyst charged in $600,000 insider trading scheme
Subscribe for More Information
13:01 EDTJNJJ&J unit to sell Splenda brand to Heartland Food, terms not disclosed
Subscribe for More Information
12:20 EDTJPMOn The Fly: Top stock stories at midday
Subscribe for More Information
11:12 EDTJPMNumerous analysts upgrade Bank of America amid market rebound
Subscribe for More Information
10:03 EDTJPMChase, Enterprise Car Sales announce multi-year private-label agreement
Subscribe for More Information
09:59 EDTJPMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:35 EDTJPMActive equity options trading on open
Subscribe for More Information
09:13 EDTJPMOn The Fly: Pre-market Movers
Subscribe for More Information
09:03 EDTJNJAcorda has major overhang removed by IPR denials, says Leerink
Subscribe for More Information
07:28 EDTJPM, JPMJPMorgan upgraded to Buy from Outperform at CLSA
CLSA analyst Mike Mayo upgraded JPMorgan to Buy from Outperform with a $78 price target. Mayo said JPMorgan offers the most stable earnings of U.S. global banks for the past decade, a resilient balance sheet, and a dividend yield above the 10 year bond that implies outperformance 85% of the time historically.
06:18 EDTJNJSears names Lynn Pendergrass as Hardlines president
Subscribe for More Information
August 24, 2015
18:02 EDTJPMS&P 500 enters correction territory amid global growth concerns
Subscribe for More Information
07:34 EDTJPMJP Morgan volatility at high end of range
Subscribe for More Information
August 21, 2015
09:01 EDTJNJLeerink medical devices analyst holds an analyst/industry conference call
Medical Device Analyst Newitter, along with MEDACorp Specialists Dorance Dillon and Terence Farrell, discuss the Centers for Medicare & Medicaid Services' recently proposed "Comprehensive Care For Joint Replacement Payment Model" and how this model might influence ortho pricing and hospital-vendor relationships on an Analyst/Industry conference call to be held on August 24 at 1 pm.
08:40 EDTJPM, CSCanadian Security Traders Association to hold a conference
Subscribe for More Information
August 20, 2015
15:56 EDTRYWindstream said to hire RBC to explore sale of data storage business
Subscribe for More Information
11:33 EDTJNJLeerink major pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
09:03 EDTJPMJPMorgan appoints General Ray Odierno as senior advisor
JPMorgan Chase & Co. announced the appointment of retired four-star General Raymond T. Odierno, former Chief of Staff of the U.S. Army, to a senior advisory capacity at the firm, effective September 1.
06:07 EDTCSSamsung Bioepis picks Citi, Goldman as lead managers for IPO, Reuters says
Samsung Bioepis has selected Citigroup (C) and Goldman Sachs (GS) as the lead managers for its planned listening on Nasdaq next year, a source tells Reuters. Morgan Stanley (MS) and Credit Suisse (CS) will also take part in the listing for Samsung's (SSNLF) biosimilar drug development arm, the source says. Reference Link
August 19, 2015
14:42 EDTJPMBanks cooperate on data company to lower costs, WSJ says
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use